STAR Apollo Mapping System

by Rhythm AI Ltd  · Based in United Kingdom → — Navigating the Complexity of Atrial Fibrillation.
Cardiology

Contact vendor for pricing
Regulatory Status Disclosed

Overview

The STAR Apollo Mapping System by Rhythm AI Ltd is an innovative AI-driven medical device designed to revolutionize the treatment of atrial fibrillation (AF). It transforms AF procedures by providing cutting-edge, real-time data analysis from existing electrophysiology (EP) systems. Powered by sophisticated AI algorithms rooted in fundamental electrophysiological principles, STAR Apollo uncovers repetitive patterns within arrhythmias and precisely pinpoints early sites of activation (ESAs) of the heart that are potential drivers of AF.

This breakthrough capability empowers physicians to craft highly personalized treatment plans tailored to each patient’s unique needs, significantly improving the diagnosis and treatment of AF. The system integrates seamlessly into current clinical workflows and is compatible with leading EP mapping systems such as Abbott’s EnSite X EP System and Johnson & Johnson’s CARTO 3 Mapping System.

Rhythm AI Ltd, a UK-based company, focuses on optimizing AF procedures and has received US Food and Drug Administration (FDA) 510k clearance for the commercial launch version of its STAR Apollo Mapping System. The system assists operators in identifying ESAs and Repetitive Patterns of Activation (RPA) during cardiac mapping procedures for AF.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Real-time data analysis from existing EP systems
  • Sophisticated AI algorithms for arrhythmia pattern recognition
  • Identification of Repetitive Patterns of Activation (RPA)
  • Pinpointing Early Sites of Activation (ESA)
  • Enables highly personalized treatment plans
  • Seamless integration into current clinical workflows
  • Summarizes and characterizes AF activation patterns
  • Identifies most frequent AF origin sites
  • Utilizes fundamental principles of electrophysiology
  • Assists in manual annotation of 3D anatomical and electrical maps

Use Cases

  • Optimizing Atrial Fibrillation (AF) procedures
  • Identifying AF origin sites
  • Creating customized AF treatment plans
  • Guiding catheter ablation procedures for AF
  • Used with Pulsed Field Ablation (PFA) or traditional radiofrequency energy delivery systems
  • Analysis of 3D anatomical and electrical maps of human atria

What Physicians Need to Know

ECG/EKG Analysis Capability
The STAR Apollo Mapping System analyzes unipolar electrograms recorded by compatible mapping systems. It filters these electrograms and determines timing by the maximum negative dV/dt. The allocated timing from the system is shown as red dots at the maximum negative dV/dt with the resultant vector represented by a green arrow.
Cardiac CT/MRI Analysis
The STAR Apollo Mapping System assists users in the interpretation and manual annotation of 3D anatomical and electrical maps of human atria using data from multipolar, intracardiac, atrial electrograms during atrial fibrillation.
Arrhythmia Detection Accuracy
The STAR Apollo Mapping System uses AI-driven algorithms to identify repetitive patterns of activation (RPAs) and early sites of activation (ESAs) in the atria, which are potential drivers of Atrial Fibrillation (AF). In a study of patients undergoing redo ablation for persistent AF, 90% were free of AF at the one-year follow-up, and 73% had no recurrence of arrhythmia at all. The system identifies regions from which electrical activation is emerging, not necessarily a specific mechanism, but a source for targeted ablation.
Real-Time Alert Capability
The STAR Apollo Mapping System allows for real-time data acquisition, analysis, and visualization by streaming electrogram data from compatible mapping systems.
Physician Tip

The STAR Apollo Mapping System is designed to assist electrophysiologists in identifying the origins of Atrial Fibrillation (AF) by analyzing intracardiac electrograms. It provides a patient-specific map of AF drivers, including repetitive patterns of activation (RPAs) and early sites of activation (ESAs), to help create customized treatment plans. The system's algorithms replicate what a physician would manually do, given sufficient time, by analyzing AF repetitive activation patterns. It is particularly useful in complex cases, such as redo ablations for persistent AF, where identifying extra-pulmonary targets is crucial for improved outcomes. The system operates outside the sterile field and provides supplementary information to guide further mapping and ablation.

The STAR Apollo Mapping System is a software-driven system that integrates with commercially approved electroanatomic mapping systems. It is compatible with Abbott's EnSite Precision Cardiac Mapping System (Model EE 3000 (V2.6) or Ensite X EP System (V 1.1.1, V 2.0, V 3.0, V 3.1)) and Johnson & Johnson MedTech's CARTO™ 3 Mapping System. The system receives real-time data analysis from the LiveSync™ data transfer function of these mapping systems. It is also designed for use with commercially approved catheters such as the Advisor™ HD Grid Mapping Catheter, Sensor Enabled™ (Abbott Medical), and is compatible with HD Grid, HD Grid X, and OPTRELL Mapping Catheter with TRUEref. The STAR Apollo System is not directly connected to the patient and does not deliver therapy; data transfer is unidirectional from the mapping system to STAR Apollo.

Details

Category Cardiology AI, Surgical AI
Pricing Contact vendor for pricing
DeploymentIntegrates with existing electrophysiology (EP) systems such as Abbott's EnSite X EP System and Johnson & Johnson's CARTO 3 Mapping System.
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Cardiology

What the Web Says

The STAR Apollo Mapping System by Rhythm AI is an AI-guided cardiac mapping system designed to identify localized sources of atrial activation during atrial fibrillation (AF) and assist physicians in developing targeted ablation strategies. It has received FDA 510(k) clearance and is compatible with major 3D mapping platforms like Abbott's EnSite X EP System and Johnson & Johnson's CARTO 3 Mapping System. The system aims to improve outcomes in complex AF cases by providing real-time data acquisition, analysis, and visualization of electrogram data.

Overall: Positive

Strengths

  • AI-guided technology identifies origins of AF regardless of underlying mechanisms.
  • Provides precise, patient-specific maps of where AF originates by identifying patterns of activation.
  • Enables physicians to build targeted, discrete, and efficient ablation strategies.
  • Allows real-time data acquisition, analysis, and visualization by streaming electrogram data.
  • Demonstrated improved long-term arrhythmic outcomes in patients with persistent AF in single-center studies.
  • Compatible with leading 3D mapping platforms (Abbott's EnSite X EP System and Johnson & Johnson's CARTO 3 Mapping System).

Limitations

  • The clinical significance of utilizing the system to help identify areas with intracardiac atrial electrograms of atrial arrhythmias has not been established by clinical investigations.
  • The system makes no assumptions of arrhythmia mechanism and does not prescribe any standardized treatment recommendations.
  • STAR Mapping had not been cleared by any regulatory authority in the world and was not available for clinical use as of a 2022 presentation.

Based on reviews from: firstwordhealthtech.com, researchgate.net, healthaidb.com, fda.gov, londonafcentre.com, investing.com, nih.gov, revmedconnect.com

Last updated: 2026-10-31

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate STAR Apollo Mapping System

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

BioSpace
Rhythm AI's STAR Apollo Mapping Technology Demonstrates 90% of Patients Experienced Freedom from Atrial Fibrillation (AF) at One-Year Following Redo Ablations for Persistent AF
Rhythm AI announced positive one-year results from the STAR Apollo study, showing that 90% of patients undergoing redo ablations for persistent AF were free from atrial fibrillation. The study met its primary feasibility endpoint in 100% of patients and demonstrated a strong safety profile.
2026-09
FirstWord HealthTech
Rhythm AI: FDA clearance for new STAR Apollo™ Mapping System
Rhythm AI received FDA 510k clearance for its STAR Apollo Mapping System, expanding its compatibility to include Johnson & Johnson MedTech's CARTO™ 3 Mapping System. This allows the system to optimize AF procedures with real-time data analysis from CARTO, enabling customized treatment plans.
2026-01
Investing.com
Rhythm AI secures FDA clearance for STAR Apollo mapping system
Rhythm AI Ltd. announced FDA 510(k) clearance for its STAR Apollo Mapping System, now compatible with Johnson & Johnson MedTech's CARTO 3 Mapping System. The company plans a limited market release in the US in early 2026 for this AI-powered system that identifies AF drivers.
2026-01
Pharmafile
Rhythm AI's STAR Apollo system receives FDA clearance for atrial fibrillation
Rhythm AI's STAR Apollo Mapping System received 510k FDA clearance for use in atrial fibrillation, with increased compatibility for Johnson & Johnson's CARTO 3 Mapping System. The system uses AI algorithms to identify heart regions associated with AF, enabling personalized treatment plans.
2026-02
IPT Online
Rhythm AI Announces FDA Clearance of the Commercial Release Version of STAR Apollo Mapping System
Rhythm AI Ltd. announced FDA 510k clearance for the commercial launch version of its STAR Apollo Mapping System, following successful first-in-human cases. The system optimizes AF treatment with real-time data analysis from Abbott's EnSite X EP System, using AI to identify AF drivers.
2024-09
FirstWord HealthTech
Rhythm AI's STAR Apollo™ Mapping System to be featured during live case transmission at 31st Annual International AF Symposium
Rhythm AI announced that its STAR Apollo Mapping System will be featured during a live case transmission at the 31st Annual International AF Symposium. The procedure will use STAR Apollo with Abbott's EnSiteX™ 3D Mapping System and LiveSync™ data streaming to optimize AF ablation.
2026-02
Rhythm AI
Rhythm AI Appoints Medtech Veteran Mike Dineen as Chief Executive Officer
Rhythm AI appointed Mike Dineen as CEO to lead the company's US clinical and commercial expansion. Dineen joins at a pivotal time, following FDA 510(k) clearances for the STAR Apollo Mapping System's compatibility with both Johnson & Johnson's CARTO™ 3 and Abbott's EnSite™ X EP Systems.
2026-06
FDA
FDA 510(k) Premarket Notification for STAR Apollo™ Mapping System
The FDA granted 510(k) clearance for the STAR Apollo Mapping System, which assists in interpreting 3D anatomical and electrical maps of human atria during atrial fibrillation. The system identifies Repetitive Patterns of Activation (RPA) and Early Sites of Activation (ESA) to help clinicians locate AF origins.
2025-12

Videos

Product demos, reviews, and walkthroughs for STAR Apollo Mapping System.

View all on YouTube

Frequently Asked Questions

The STAR Apollo Mapping System is an AI-powered software developed by RHYTHM AI that analyzes real-time electrogram data during atrial fibrillation (AF) procedures. It identifies repetitive patterns of activation (RPAs) and early sites of activation (ESAs) within the atria, which are potential drivers of AF. This information helps physicians create personalized treatment plans for patients undergoing ablation procedures.
The STAR Apollo Mapping System aims to optimize AF procedures by providing real-time analysis of data to pinpoint AF drivers. This allows for more targeted and tailored ablation strategies, potentially leading to improved patient outcomes, especially in cases of recurrent or persistent AF where previous ablations have been insufficient.
Yes, the STAR Apollo Mapping System has received FDA 510k clearance. It is compatible with commercially approved electroanatomic mapping systems, specifically Abbott's EnSiteX™ 3D Mapping System with LiveSync™ data streaming and Johnson & Johnson MedTech's CARTO™ 3 Mapping System.
While promising, the clinical significance of using the STAR Apollo Mapping System to identify areas with intracardiac atrial electrograms for atrial arrhythmias has not been established by multi-center randomized clinical investigations. It is intended as a software tool to provide supplementary information to the physician and is not directly connected to the patient or used to deliver therapy.
The STAR Apollo Mapping System is designed to supplement existing 3D mapping systems like EnSite X and CARTO 3 by providing AI-guided analysis of electrogram data to identify AF drivers. It differs from some other systems by focusing on identifying early electrical activation and repetitive patterns without assuming a specific AF mechanism. While other mapping methods exist, STAR Apollo aims to offer a reliable method for identifying ablation targets, especially in complex cases.
The pricing or cost structure for the STAR Apollo Mapping System is not publicly available. Information regarding pricing for medical devices is typically handled through direct inquiries with the company or its sales representatives.
A prospective, single-arm study (STAR Apollo study, NCT05826665) involving 50 patients undergoing redo ablation for persistent AF showed promising results. The study met its primary feasibility endpoint in 100% of patients, with 90% of patients free of AF at the one-year follow-up. These results suggest that the system's approach to locating AF drivers is effective and safe for this patient population.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-04-19 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.